ILS Hospitals

Kolkata, India Founded: 2000 • Age: 26 yrs Listed
Multispeciality healthcare is delivered through a network of hospitals.
Request Access
Report Incorrect Data
Page last updated

About ILS Hospitals

ILS Hospitals is a publicly listed company based in Kolkata (India) founded in 2000 by Om Tantia. Multispeciality healthcare is delivered through a network of hospitals. ILS Hospitals has raised $7.8 million across 2 funding rounds from investors including BanyanTree Finance. The company has 1,920 employees. Its chief executive, as recorded, is Om Tantia. Its website ilshospitals.com draws about 34 thousand monthly visits. Its Indian entity Gpt Healthcare Limited reported revenue of ₹478 Cr. ILS Hospitals offers products and services including Bariatric Surgery, Cardiology Services, Emergency Care, and General Surgery. Its focus areas include Hospital Chains and Multispecialty Hospital Chains. Its competitors include Fortis Healthcare, Ujala Cygnus and Narayana Health; 2 of its 3 listed competitors have raised funding.

Company details

ILS Hospitals was established in 2000 as a network of multispeciality hospitals based in Kolkata, India. Operations focus on a wide range of medical services, including bariatric surgery, oncology, cardiology, neurology, orthopaedics, and paediatrics. Additional specialties encompass gastroenterology, nephrology, urology, and obstetrics. The network supports comprehensive patient care across these domains in the healthcare sector.

  • Headquarters Kolkata, India
  • Employees 1,920
  • Founders Om Tantia
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website ilshospitals.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Gpt Healthcare Limited
Operational Areas
Healthcare → Hospitals & Clinical Care
Key Metrics
  • Market Cap
    ₹1,123 Cr

    GPTHEALTH · NSE

  • Share Price
    ₹132.68

    -3.08% today

  • Revenue
    ₹337 Cr

    FY 2021-22 · +39.0% YoY

  • EBITDA
    ₹73.84 Cr

    Margin 21.9%

  • Net Profit
    ₹41.67 Cr

    FY 2021-22 · +102.1% YoY

  • P/E (TTM)
    25.8x

    P/B 5.4x

  • ROE
    28.5%

    ROCE 23.5%

  • Debt / Equity
    0.75

    Interest cover 18.5x

  • Total Equity Funding
    $7.8M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.5M (USD), Private Equity Round

    Jun 2016

  • Investors
    BanyanTree Finance
  • Employee Count
    1,920

Products & Services of ILS Hospitals

ILS Hospitals offers a comprehensive portfolio of products and services, including Bariatric Surgery, Cardiology Services, Emergency Care, and General Surgery.

Bariatric Surgery
Surgical Services

Procedures for weight loss and metabolic health management.

Cardiology Services
Heart Care

Diagnostic and treatment options for heart conditions.

Emergency Care
Critical Services

24x7 support for urgent medical situations.

General Surgery
Surgical Services

Routine and laparoscopic surgical interventions.

Apps and channels of ILS Hospitals

its YouTube channel ILS Hospitals - Multispeciality Hospital Chain has 753 subscribers and 30 videos.

ILS Hospitals - Multispeciality Hospital Chain
YouTube 753 subscribers 30 videos Howto & Style
Open channel

Videos from ILS Hospitals

The most watched videos on ILS Hospitals's YouTube channel, ILS Hospitals - Multispeciality Hospital Chain (753 subscribers). Click a video to play it here.

ILS Hospitals Raipur – Now Open!
123.2K views
Hum Dil Se Kaam Karte Hai - ILS Hospitals Howrah: Excellence in Healthcare
2.4K views
Admission open for Nursing Training at ILS Nursing Institute, Agartala. Session 2024-2025.
1K views
A Family's Journey to Health: Reena Pandey and Her Children's Inspiring Bariatric Surgery Experience
963 views

More on ILS Hospitals - Multispeciality Hospital Chain.

Funding Insights of ILS Hospitals

ILS Hospitals has successfully raised a total of $7.8M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $1.5 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $7.8M
  • Total Rounds 2
  • Last Round Private Equity Round — $1.5M
  • First Round $6.3M

    (Nov 2014)

  • Investors Count 1

All 2 funding rounds of ILS Hospitals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2016$1.5MPrivate Equity Round––
BanyanTree Finance
Nov 2014$6.3MPrivate Equity Round––
BanyanTree Finance
Valuation history

1 investors in total: 1 institutional.

Investors in ILS Hospitals

ILS Hospitals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include BanyanTree Finance.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
BanyanTree Finance
Investment firm engaging in diverse sector partnerships in India.
2008banyantreefinance.comMumbai, India
Premium access

Investor details for ILS Hospitals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Gpt Healthcare Limited (ILS Hospitals)

Gpt Healthcare Limited is the primary company behind ILS Hospitals. The board of Gpt Healthcare Limited currently have 10 directors; the longest-serving is Om Tantia, appointed in 2005. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Om Tantia
DIN 00001342
Managing Director10 Jan 200521 yrs 9 moGpt Healthcare Limited
Aruna Tantia
DIN 00001347
Director04 Apr 200521 yrs 6 moGpt Healthcare Limited
Ghanshyam Goyal
DIN 00234246
Director29 Apr 200620 yrs 6 moGpt Healthcare Limited
Anurag Tantia
DIN 03118844
Whole-time director02 Oct 201115 yrsGpt Healthcare Limited
Hari Modi
DIN 00801413
Director15 Sep 20215 yrs 1 moGpt Healthcare Limited
Tapti Sen
DIN 06730644
Director15 Sep 20215 yrs 1 moGpt Healthcare Limited
Kashi Prasad Khandelwal
DIN 00748523
Director27 Sep 20233 yrs 1 moGpt Healthcare Limited
Amrendra Prasad Verma
DIN 00236108
Director27 Sep 20233 yrs 1 moGpt Healthcare Limited
Deepak Pramanik
DIN 00762567
Director27 Sep 20233 yrs 1 moGpt Healthcare Limited
Shree Gopal Tantia
DIN 00001346
Director24 Sep 20251 yr 1 moGpt Healthcare Limited

People of ILS Hospitals

4 people are tracked at ILS Hospitals (3 in leadership, 1 in team); the tracked headcount is 1,920.

NameRoleGroup
Om Tantia
Founder & MDLeadership
Dr Sanjay Kant Mishra
EX Chief Operating OfficerLeadership
Debashis Dhar
Sr.vice President & Chief Business DevelopmentLeadership
Priyatosh Ghosh
Senior Executive Human ResourcesTeam
Premium access

Complete people profiles for ILS Hospitals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of ILS Hospitals

ILS Hospitals is a publicly listed company on the NSE with ticker symbol GPTHEALTH in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date29 Feb 2024
  • Listed onBSE: 544131 · NSE: GPTHEALTH
  • Listed entityGPT Healthcare Limited
  • Exchange sectorHealth services
  • ISININE486R01017
  • Share price₹141.16 (-0.65% on the day) · 2026-10-14
  • Market capitalisation₹1,170 Cr
  • Price to earnings24.5
  • EPS (diluted, trailing year)₹5.76
  • Dividend yield1.75%
  • Volume (last session)46,680

Financials of ILS Hospitals

Exchange-reported figures of Gpt Healthcare Limited, the listed company behind ILS Hospitals (NSE: GPTHEALTH).

Financial Highlights

FY 2021-22 · Consolidated
Revenue
₹337 Cr
+39.0% YoY
EBITDA
₹73.84 Cr
+50.7% YoY
Profit After Tax
₹41.67 Cr
+102.1% YoY
Net Worth
₹158 Cr
+18.2% YoY
Total Assets
₹278 Cr
0.0% YoY
Total Debt
₹95.52 Cr
-22.3% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue337243212
Revenue growth+39.0%+14.6%-
EBITDA73.8448.9935.79
EBITDA margin+21.9%+20.2%+16.9%
Profit before tax54.0928.8814.82
Net profit41.6720.6211.07
Net profit margin+12.4%+8.5%+5.2%
EPS (₹)5.2211.766.11
Balance sheet
Total assets278278263
Net worth158134127
Total debt95.52123117
Cash & bank8.715.000.56
Net working capital34.8946.9816.81
Cash flow
Cash from operations65.9942.9941.47
Cash from investing(5.34)(16.45)(54.31)
Cash from financing(57.16)(22.11)11.91
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue473407400361337243212
Revenue growth+16.1%+1.7%+10.8%+7.0%+39.0%+14.6%-
EBITDA84.1983.3587.8474.3673.8348.9935.79
EBITDA margin+17.8%+20.5%+22.0%+20.6%+21.9%+20.2%+16.9%
Profit before tax54.8169.3468.0455.9854.0828.8814.82
Net profit43.0949.4547.8538.6741.6020.6211.08
Net profit margin+9.1%+12.2%+12.0%+10.7%+12.3%+8.5%+5.2%
EPS (₹)5.156.085.824.885.2111.766.11
Balance sheet
Total assets380303268267279278263
Net worth269248218165158134127
Total debt91.1835.3030.5482.35102126117
Cash & bank4.484.279.138.858.715.000.56
Net working capital(18.65)(14.83)3.3316.7635.9547.6016.81
Cash flow
Cash from operations81.1667.4068.8066.3665.9942.9941.46
Cash from investing(47.25)(32.59)(25.21)5.15(5.34)(16.45)(54.31)
Cash from financing(31.43)(34.84)(48.50)(73.18)(57.16)(22.11)11.91
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue126126120119107101102106
Revenue growth (YoY)+17.8%+24.6%+17.6%+12.5%+9.5%---
Other income2.031.631.421.341.561.571.882.80
Total expenses10210399.4596.1789.7480.7180.9482.24
EBITDA24.1823.3720.7122.7417.3720.6921.2723.42
EBITDA margin+19.2%+18.5%+17.2%+19.1%+16.2%+20.4%+20.8%+22.2%
Depreciation6.886.957.116.856.184.884.674.80
Interest2.162.182.262.161.631.020.850.74
Profit before tax17.1715.8712.7615.0711.1216.3617.6320.68
Tax4.431.303.394.473.433.485.375.87

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 31 Oct 2026
ParticularsFY 2021-22FY 2020-21FY 2019-20
Revenue337243212
Revenue growth+39.0%+14.6%-
Other income4.996.114.23
Total expenses264194176
Employee cost53.7841.6642.04
EBITDA73.8448.9935.79
EBITDA margin+21.9%+20.2%+16.9%
Depreciation13.5912.4711.08
Interest11.1513.7514.12
Profit before tax54.0928.8814.82
Tax12.417.793.89
Net profit41.6720.6211.07
Net profit margin+12.4%+8.5%+5.2%
EPS (₹)5.2211.766.11
ParticularsFY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital79.9017.9417.94
Reserves & surplus78.2875.9368.88
Shareholders' funds (net worth)158134127
Minority interest0.000.000.00
Secured loans95.52123107
Unsecured loans0.000.009.90
Total debt95.52123117
Total liabilities278278263
Assets
Gross block279266260
Net block220220226
Capital work in progress0.720.291.77
Investments10.390.680.68
Inventories7.286.436.30
Sundry debtors13.4317.2617.31
Cash & bank balances8.715.000.56
Loans & advances50.8757.6538.48
Total current assets80.2986.3462.65
Total current liabilities45.4039.3645.84
Net working capital34.8946.9816.81
Total assets278278263
ParticularsFY 2021-22FY 2020-21FY 2019-20
Opening cash4.780.351.28
Net cash from operating activities65.9942.9941.47
Net cash from investing activities(5.34)(16.45)(54.31)
Net cash from financing activities(57.16)(22.11)11.91
Net change in cash3.494.43(0.93)
Closing cash8.715.000.56
ParticularsFY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+39.0%+14.6%-
EBITDA growth+50.7%+36.9%-
PBT growth+87.3%+94.9%+9997.0%
Net income growth+102.1%+86.3%-
Profitability & leverage
Net income margin+12.4%+8.7%+5.2%
Return on capital employed+23.5%+15.8%+11.0%
Return on net worth+28.5%+16.2%+8.6%
Debt / equity0.750.920.92
Long-term debt / equity0.530.590.59
Interest cover18.5137.6557.14
Efficiency & per share
Fixed asset turnover1.240.920.81
Inventory turnover49.2238.1433.63
Debtors turnover21.9914.0412.24
EPS (₹)5.2211.766.11
Dividend per share (₹)6.005.500.00
Book value per share (₹)19.8052.3248.39
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue126126120119107101102106
Revenue growth (YoY)+17.8%+24.6%+17.6%+12.5%+9.5%---
Other income2.031.631.421.341.561.571.882.80
Total expenses10210399.4596.1789.7480.7180.9482.24
EBITDA24.1823.3720.7122.7417.3720.6921.2723.42
EBITDA margin+19.2%+18.5%+17.2%+19.1%+16.2%+20.4%+20.8%+22.2%
Depreciation6.886.957.116.856.184.884.674.80
Interest2.162.182.262.161.631.020.850.74
Profit before tax17.1715.8712.7615.0711.1216.3617.6320.68
Tax4.431.303.394.473.433.485.375.87
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue473407400361337243212
Revenue growth+16.1%+1.7%+10.8%+7.0%+39.0%+14.6%-
Other income5.958.495.295.694.996.114.23
Total expenses388324312287264194176
Employee cost84.3673.0268.9362.0453.7841.6642.04
EBITDA84.1983.3587.8474.3673.8348.9935.79
EBITDA margin+17.8%+20.5%+22.0%+20.6%+21.9%+20.2%+16.9%
Depreciation27.0919.0317.9814.9113.5912.4711.08
Interest8.243.477.119.1611.1513.7514.12
Profit before tax54.8169.3468.0455.9854.0828.8814.82
Tax12.5919.4320.2716.9612.417.793.88
Net profit43.0949.4547.8538.6741.6020.6211.08
Net profit margin+9.1%+12.2%+12.0%+10.7%+12.3%+8.5%+5.2%
EPS (₹)5.156.085.824.885.2111.766.11
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital82.0582.0582.0579.9079.9017.9417.94
Reserves & surplus18716613685.4678.2875.9668.91
Shareholders' funds (net worth)269248218165158134127
Secured loans16.1113.3012.4264.6775.88120107
Unsecured loans75.0722.0018.1217.6825.685.399.90
Total debt91.1835.3030.5482.35102126117
Total liabilities380303268267279278263
Assets
Gross block468327306296279266260
Net block342228224228220220226
Capital work in progress0.7146.336.402.610.720.291.77
Investments42.9431.9830.3513.4410.390.710.71
Inventories10.608.838.158.927.286.436.30
Sundry debtors20.2819.7024.2820.6813.4317.2617.31
Cash & bank balances4.484.279.138.858.715.000.56
Loans & advances10.9814.0427.4134.5550.8757.6538.48
Total current assets46.3446.8468.9773.0080.2986.3462.65
Total current liabilities64.9961.6765.6456.2444.3438.7445.84
Net working capital(18.65)(14.83)3.3316.7635.9547.6016.81
Total assets380303268267279278263
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash1.661.696.608.274.780.351.28
Net cash from operating activities81.1667.4068.8066.3665.9942.9941.46
Net cash from investing activities(47.25)(32.59)(25.21)5.15(5.34)(16.45)(54.31)
Net cash from financing activities(31.43)(34.84)(48.50)(73.18)(57.16)(22.11)11.91
Net change in cash2.47(0.03)(4.91)(1.67)3.494.43(0.93)
Closing cash4.484.279.138.858.715.000.56
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+16.1%+1.7%+10.8%+7.0%+39.0%+14.6%-
EBITDA growth+1.0%-5.1%+18.1%+0.7%+50.7%+36.9%-
PBT growth-21.0%+1.9%+21.5%+3.5%+87.3%+94.9%+9997.0%
Net income growth-12.9%+3.3%+23.7%-7.0%+101.8%+86.1%-
Revenue CAGR (3Y)+9.4%+6.5%+18.1%+19.5%---
EBITDA CAGR (3Y)+4.2%+4.1%+21.5%+27.6%---
Profitability & leverage
Net income margin+8.9%+12.3%+11.9%+10.8%+12.4%+8.7%+5.2%
Return on capital employed+18.5%+25.5%+28.1%+23.9%+23.4%+15.8%+11.0%
Return on net worth+16.3%+21.4%+24.9%+24.1%+28.5%+16.2%+8.6%
Debt / equity0.240.140.290.570.780.930.92
Long-term debt / equity0.190.090.200.410.550.590.59
Interest cover14.435.3910.1815.4118.5137.6557.14
Efficiency & per share
Fixed asset turnover1.191.291.331.261.240.920.81
Inventory turnover48.6447.9546.8944.5749.2238.1433.63
Debtors turnover23.6418.5117.8021.1721.9914.0412.24
EPS (₹)5.156.085.824.885.2111.766.11
Dividend per share (₹)2.502.503.505.000.005.500.00
Book value per share (₹)32.8430.2126.6320.7019.8052.3448.41

Timeline of ILS Hospitals

4 dated milestones of ILS Hospitals across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded ILS Hospitals is founded.
  2. Funding First funding round of $6.3M.
  3. Funding Latest funding round, Private Equity Round, of $1.5M.
  4. IPO Lists on the stock exchange (IPO).

Competitors of ILS Hospitals

ILS Hospitals has 3 listed competitors in our database, 2 of them funded. They include Fortis Healthcare, Ujala Cygnus and Narayana Health.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Fortis Healthcare
fortishealthcare.com1996Gurugram, India1,565
Multi-specialty hospital services are provided across India by Fortis Healthcare.
Ujala Cygnus
ujalacygnus.com2011Delhi, India$36.74M2,084
A chain of multi-specialty hospitals is operated in India.
Narayana Health
narayanahealth.org2000Bengaluru, India$148.2M8,145
A chain of multi-specialty hospitals is operated in India.
Premium access

Detailed competitors of ILS Hospitals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ILS Hospitals

The website of ILS Hospitals (ilshospitals.com) receives about 34K visits a month.

  • Monthly visits
    34K

    ▲ 46.9% vs previous month

Similar websites

Websites whose visitors overlap most with ILS Hospitals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Kothari Medical
kotharimedical.com
100%
20.4K#1,170,403View details
Desun Hospital
desunhospital.com
98%
28.1K#994,941View details
nrsmc.edu.in
nrsmc.edu.in
97%
#768,660–
Ruby General Hospital
rubyhospital.com
97%
15.7K#1,413,070View details
Neotia Bhagirathi Woman and Child Care Centre
neotiahospital.com
95%
#2,664,231View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for ILS Hospitals

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Hospitals & Clinical Care

3 companies that operate in the same segment as ILS Hospitals (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Cloudnine
Maternity, childcare, and fertility services are delivered via hospital chains.
2007Bengaluru, Karnataka, IndiaUSD 204.87 MUSD 140.46 M4,459
HCG
Chain of oncology hospitals
1989Bengaluru, Karnataka, IndiaUSD 36.59 MUSD 270.51 M8,400
Medanta
Chain of multi-super specialty healthcare hospitals
2004Gurugram, Haryana, IndiaUSD 104.7 MUSD 461.72 M12,240
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ils Hospitals

GPT Infraprojects Unit Declared L1 Bidder For Order Worth 973.1 Million Rupees
Reuters • 2 months ago
GPT Infraprojects' Unit Declared L1 In Order Valued At 725 Million Rupees
Reuters • 2 months ago
GPT Healthcare standalone net profit rises 65.76% in the June 2026 quarter | Capital Market News - Business Standard
Business Standard • 2 months ago
GPT Healthcare June-Quarter PAT 127.3 Million Rupees
Reuters • 2 months ago
Q1 results today: Divi's Labs, Muthoot Finance, APL Apollo among over 30 companies set to announce Q1 earnings
Mint • 3 months ago
Gpt Infraprojects Announces Contract Win Valued At 720 Million Rupees
Reuters • 5 months ago
GPT Infraprojects March-Quarter Consol Net Profit 318.8 Million Rupees
Reuters • 5 months ago
Gpt Healthcare Ltd Dec-Quarter PAT 93.7 Million Rupees
Reuters • 9 months ago
GPT Infraprojects Approved Acquisition Of 100% Stake In Alcon Builders And Engineers For 1.54 Billion Rupees
Reuters • 9 months ago
GPT Infraprojects Says JV Wins Contract From National Highway Authority Of India
Reuters • 10 months ago
Premium access

Complete news archive for ILS Hospitals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ILS Hospitals

ILS Hospitals was founded in 2000 and raised its 1st funding round 14 years after it was founded.

ILS Hospitals is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.

Om Tantia is the CEO of ILS Hospitals, as recorded in our data.

ILS Hospitals is a funded company, having raised a total of $7.8M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $6.3M, raised on Nov 2014.

ILS Hospitals has 1,920 employees.

The primary company behind ILS Hospitals, Gpt Healthcare Limited, reported revenue of ₹478 Cr for FY 2026, up 16% year on year.

ILS Hospitals was established in 2000 as a network of multispeciality hospitals based in Kolkata, India. Operations focus on a wide range of medical services, including bariatric surgery, oncology, cardiology, neurology, orthopaedics, and paediatrics. Additional specialties encompass gastroenterology, nephrology, urology, and obstetrics. The network supports comprehensive patient care across these domains in the healthcare sector.

ILS Hospitals's top competitors include Fortis Healthcare, Ujala Cygnus and Narayana Health.

ILS Hospitals offers Bariatric Surgery, Cardiology Services, Emergency Care, and General Surgery.

Yes, ILS Hospitals is publicly traded on NSE under the ticker symbol GPTHEALTH.

ILS Hospitals has 1 investor. Key investors include BanyanTree Finance.

ILS Hospitals operates through Gpt Healthcare Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available